Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
230.4 USD | -1.75% | -2.92% | -5.53% |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.1 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.93 times its current sales, is high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.53% | 67.76B | A | ||
-5.31% | 182B | C+ | ||
-1.21% | 114B | C | ||
+1.22% | 51.91B | B- | ||
+7.03% | 43.23B | B- | ||
+6.07% | 41.07B | B+ | ||
+21.96% | 32.07B | B | ||
+15.86% | 25B | A- | ||
-4.81% | 24.55B | B | ||
-6.68% | 24.35B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BDX Stock
- Ratings Becton, Dickinson and Company